Drug Database
Back to search

Belgium· BE-AMP-SAM665502-00

Shingrix

A zoster, gereinigtes antigen product containing varicella zoster virus, recombinant, adjuvanted, registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 10 of our 19 countries.

ATC J07BK03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedShingrixATCJ07BK03REGISTER NO.BE-AMP-SAM665502-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about varicella zoster virus, recombinant, adjuvantedAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zoster, gereinigtes antigen is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BK03 (zoster, gereinigtes antigen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search zoster, gereinigtes antigen products by name

Zoster, gereinigtes antigen · ATC J07BK03

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Varicella Zoster Virus, Recombinant, Adjuvanted
Manufacturer
GlaxoSmithKline Biologicals
Country
Belgium (BE)
ATC code
J07BK03
ATC class
Zoster, gereinigtes Antigen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BK03

Zoster, gereinigtes antigen, as other registers publish it.

All zoster, gereinigtes antigen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8bc5dd04-4d03-4145-9d05-080c7571aab8
GET /v1/drugs/8bc5dd04-4d03-4145-9d05-080c7571aab8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection in pre-filled syringe",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Shingrix",
  "name_fr": "Shingrix",
  "name_nl": "Shingrix",
  "amp_code": "SAM665502-00",
  "strengths": [
    "0.0800"
  ],
  "pack_count": 2,
  "substances": [
    "Varicella Zoster Virus, Recombinant, Adjuvanted",
    "Dipotassium Hydrogen Phosphate",
    "Disodium Hydrogen Phosphate",
    "Potassium Dihydrogen Phosphate",
    "Sodium Chloride",
    "Sodium Dihydrogen Phosphate Dihydrate",
    "Sucrose",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Zoster, Purified Antigen",
  "authorisation_numbers": [
    "EU/1/18/1272/004",
    "EU/1/18/1272/003"
  ]
}
API referenceMCP serverPlans

See everything about zoster, gereinigtes antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console